US equities
|
NVDA
$125.84
▼-13.80%
ANT
$88.30
▼-9.13%
MU
$594.73
▼-13.86%
AMD
$424.31
▼-13.26%
AAPL
$342.85
▼-1.82%
MSFT
$484.96
▼-2.68%
AMZN
$247.13
▼-3.98%
AVGO
$304.65
▼-12.12%
NVDA
$125.84
▼-13.80%
ANT
$88.30
▼-9.13%
MU
$594.73
▼-13.86%
AMD
$424.31
▼-13.26%
AAPL
$342.85
▼-1.82%
MSFT
$484.96
▼-2.68%
AMZN
$247.13
▼-3.98%
AVGO
$304.65
▼-12.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Reunion Neuroscience Inc/
Recent news which mentions Reunion Neuroscience Inc/
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Market News
Next/Generation Psychedelics
Global
From
Benzinga
Former Field Trip Health, Now Reunion Neuroscience: Q1 2023 Financial Results & Corporate Reorganization
August 16, 2022
Tags
Benzinga
Earnings
Global
From
Benzinga
Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia
July 21, 2022
Tags
Field Trip Health Ltd
Markets
Reunion Neuroscience Inc/
From
Benzinga
Field Trip Health To Divide Into Two Separate Public Companies
April 29, 2022
Tickers
FTRP
Tags
Field Trip Health
Cannabis
Field Trip Health and Wellness Ltd/
From
Benzinga